Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Combined Oral Contraceptive Pill and Resistance Starch [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of a Combined Oral Contraceptive Pill and resistant starch in adults with Metabolic Syndrome or Polyc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combined Oral Contraceptive Pill
  • Resistant starch (Resistant starch)

Snippet

Sponsor: University of Pennsylvania | Conditions: Metabolic Syndrome, Polycystic Ovary Syndrome | Phase 2 | Status: RECRUITING